| AAV production everywhere: a simple, fast, and reliable protocol for in‐house AAV vector production based on chloroform extraction M Negrini, G Wang, A Heuer, T Björklund, M Davidsson Current Protocols in Neuroscience 93 (1), e103, 2020 | 40 | 2020 |
| A comparison of AAV-vector production methods for gene therapy and preclinical assessment M Davidsson, M Negrini, S Hauser, A Svanbergsson, M Lockowandt, ... Scientific reports 10 (1), 21532, 2020 | 21 | 2020 |
| Sequential or simultaneous injection of preformed fibrils and AAV overexpression of alpha-synuclein are equipotent in producing relevant pathology and behavioral deficits M Negrini, G Tomasello, M Davidsson, A Fenyi, C Adant, S Hauser, ... Journal of Parkinson's disease 12 (4), 1133-1153, 2022 | 15 | 2022 |
| Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson’s Disease M Jewett, E Dickson, K Brolin, M Negrini, I Jimenez-Ferrer, M Swanberg Frontiers in Neurology 9, 222, 2018 | 12 | 2018 |
| Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests F Gubinelli, G Cazzolla, M Negrini, I Kulacz, A Mehrdadian, G Tomasello, ... Behavioural Brain Research 429, 113887, 2022 | 8 | 2022 |
| Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats F Gubinelli, L Sarauskyte, C Venuti, I Kulacz, G Cazzolla, M Negrini, ... Current Research in Neurobiology 4, 100065, 2023 | 3 | 2023 |
| Development and Characterisation of a Rat Model of Parkinson's Disease M Negrini | | 2022 |
